Who invested in Vaxin?
Vaxin's investors include Novartis Venture Fund, HealthCap, Truffle Capital and Redmont Capital.
United States · Venture startup
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$16Mraised across 1 round since 2015, from 1 source
From a historical funding recordSEC filing: $8.0M sold, first sale Mar 2015
Vaxin's investors include Novartis Venture Fund, HealthCap, Truffle Capital and Redmont Capital.
Vaxin has raised $16M across 1 round since 2015.
Vaxin's most recent round was a Venture of $16M in Feb 2015.
Its most recent round, $16M in Feb 2015, is also its largest on record.
Vaxin's first round on record, in Feb 2015, was backed by Novartis Venture Fund, HealthCap and Truffle Capital and 1 others.
Vaxin's latest named round is a Venture, in Feb 2015.
Vaxin is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.